Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >API >Blood System Drugs >Anticoagulant and Antiplatelet Drugs >edoxaban

edoxaban

edoxaban Structure
  • ₹0
  • Product name: edoxaban
  • CAS: 480449-70-5
  • MF: C24H30ClN7O4S
  • MW: 548.06
  • EINECS:859-181-7
  • MDL Number:MFCD13195544
  • Synonyms:EthanediaMide, N1-(5-chlo...;edoxaban;N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide;DU-176;Edoxaban(DU-176);Edoxaban N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide;5- chloro -2- pyridine -N, N-dimethyl formamidine;Edoxaban Tosylate Hydrate 2
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Melting point :>213°C (dec.)
Density :1.43
storage temp. :Hygroscopic, Refrigerator, under inert atmosphere
solubility :Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly, Heated)
pka :9.46±0.70(Predicted)
form :Solid
color :White to Off-White
InChIKey :HGVDHZBSSITLCT-JLJPHGGASA-N
SMILES :C(NC1=NC=C(Cl)C=C1)(=O)C(N[C@H]1CC[C@H](C(N(C)C)=O)C[C@H]1NC(C1=NC2CCN(C)CC=2S1)=O)=O
LogP :-1.455

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H373 May cause damage to organs through prolonged or repeated exposure Specific target organ toxicity, repeated exposure Category 2 Warning P260, P314, P501
Precautionary statements:
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P314 Get medical advice/attention if you feel unwell.
P501 Dispose of contents/container to..…

Description

Edoxaban is a direct factor Xa inhibitor. The inhibition of factor Xa in the coagulation cascade leads to an anticoagulant effect. Edoxaban is administered orally, at a dosage of 60 mg once daily, and the drug’s current proposed indication is for the prevention of stroke and systemic embolism in patients with AF.?

Related product price